CHRNA4 Antikörper (AA 531-627)
Kurzübersicht für CHRNA4 Antikörper (AA 531-627) (ABIN736746)
Target
Alle CHRNA4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 531-627
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CHRNA4
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CHRNA4 (Cholinergic Receptor, Nicotinic, alpha 4 (CHRNA4))
-
Andere Bezeichnung
- CHRNA4
-
Hintergrund
-
Synonyms: EBN, BFNC, EBN1, NACHR, NACRA4, NACHRA4, Neuronal acetylcholine receptor subunit alpha-4, CHRNA4
Background: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane permeable to sodium ions.
-
Gen-ID
- 1137
-
UniProt
- P43681
-
Pathways
- Synaptic Membrane
Target
-